{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:19:23Z","timestamp":1791879563873,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jchromb.2019.121910","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T07:48:01Z","timestamp":1575272881000},"page":"121910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Development and validation of a high-performance liquid chromatographic method with a fluorescence detector for the analysis of epirubicin in human urine and plasma, and its application in drug monitoring"],"prefix":"10.1016","volume":"1136","author":[{"given":"Natalia","family":"Treder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Maliszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Ol\u0119dzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mi\u0119kus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"B\u0105czek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Bie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata Anna","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Adamkiewicz-Dro\u017cynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Plenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2019.121910_b0005","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.3390\/ijms19113480","article-title":"Anthracyclines as Topoisomerase II poisons: from early studies to new perspectives","volume":"19","author":"Marinello","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jchromb.2019.121910_b0010","first-page":"2017","article-title":"Oxidative stress and cellular response to doxorubicin: a common factor in the complex milieu of anthracycline cardiotoxicity","volume":"13","author":"Cappetta","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jchromb.2019.121910_b0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00059-011-3470-3","article-title":"Mechanisms and management of doxorubicin cardiotoxicity","volume":"36","author":"Shi","year":"2011","journal-title":"Herz"},{"key":"10.1016\/j.jchromb.2019.121910_b0020","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1016\/j.ejca.2015.07.031","article-title":"Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis","volume":"51","author":"Yamaguchi","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jchromb.2019.121910_b0025","doi-asserted-by":"crossref","unstructured":"H. Li, B. Hu, Z. Guo, X. Jiang, X. Su, X. Zhang, Correlation of UGT2B7 polymorphism with cardiotoxicity in breast cancer patients undergoing epirubicin\/cyclophosphamide-docetaxel adjuvant chemotherapy, Yonsei Med. J. 60 (2019) 30\u201337. 10.3349%2Fymj.2019.60.1.30.","DOI":"10.3349\/ymj.2019.60.1.30"},{"key":"10.1016\/j.jchromb.2019.121910_b0030","article-title":"The role of iron in anthracycline cardiotoxicity","volume":"25","author":"Gammella","year":"2014","journal-title":"Front. Pharm. 5"},{"key":"10.1016\/j.jchromb.2019.121910_b0035","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/bcr2894","article-title":"Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer","volume":"13","author":"Parmar","year":"2011","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.jchromb.2019.121910_b0040","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11845-014-1135-y","article-title":"Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery","volume":"184","author":"Mongan","year":"2015","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.jchromb.2019.121910_b0045","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3906\/sag-1203-69","article-title":"Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation","volume":"44","author":"\u00d6zg\u00fcl","year":"2014","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.jchromb.2019.121910_b0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/pbc.20660","article-title":"Fatal pneumonitis in children with metastatic rhabdomyosarcoma following whole lung radiotherapy and sequential epirubicin","volume":"48","author":"Prestwich","year":"2007","journal-title":"Pediatr. Blood Cancer."},{"key":"10.1016\/j.jchromb.2019.121910_b0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10495-018-1450-2","article-title":"Epirubicin induces apoptosis in osteoblasts through death-receptor and mitochondrial pathways","volume":"23","author":"Huang","year":"2018","journal-title":"Apoptosis"},{"key":"10.1016\/j.jchromb.2019.121910_b0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2019.03.013","article-title":"Risk prediction model for long-term heart failure incidence after epirubicin chemotherapy for breast cancer \u2013 A real-world data-based, nationwide classification analysis","volume":"285","author":"Fogarassy","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jchromb.2019.121910_b0065","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0090-9556(25)07755-4","article-title":"Separation, Characterization, and analysis of epirubicin (4\u2019 -epidoxorubicin) and its metabolites from human urine","volume":"12","author":"Cassinelli","year":"1984","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jchromb.2019.121910_b0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF00262773","article-title":"HPLC analysis of doxorubicin, epirubicin and fluorescent metabolites in biological fluids","volume":"21","author":"Camaggi","year":"1988","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jchromb.2019.121910_b0075","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0378-4347(96)00030-8","article-title":"Determination of plasma concentrations of epirubicin and its metabolites by high-performance liquid chromatography during a 96-h infusion in cancer chemotherapy","volume":"681","author":"Barker","year":"1996","journal-title":"J. Chromatogr. B. Biomed. Appl."},{"key":"10.1016\/j.jchromb.2019.121910_b0080","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1080\/10826070701465654","article-title":"Hydrophilic interaction chromatographic determination of epirubicin in human plasma using solid phase extraction for sample clean-up","volume":"30","author":"Li","year":"2007","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jchromb.2019.121910_b0085","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/j.jchromb.2009.08.054","article-title":"Validation of an LC-MS\/MS method for the determination of epirubicin in human serum of patients undergoing Drug Eluting Microsphere-Transarterial Chemoembolization (DEM-TACE)","volume":"877","author":"Sottani","year":"2009","journal-title":"J. Chromatogr. B. Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2019.121910_b0090","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.aca.2005.04.073","article-title":"Ultra performance liquid chromatography-tandem mass spectrometry for the determination of epirubicin in human plasma","volume":"546","author":"Li","year":"2005","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2019.121910_b0095","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00007691-200308000-00003","article-title":"Determination of epirubicin and its metabolite epirubicinol in saliva and plasma by HPLC","volume":"25","author":"Dodde","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2019.121910_b0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0378-4347(97)00610-5","article-title":"Simultaneous determination of epirubicin, doxorubicin and their principal metabolites in human plasma by high-performance liquid chromatography and electrochemical detection","volume":"707","author":"Ricciarello","year":"1998","journal-title":"J. Chromatogr. B."},{"key":"10.1016\/j.jchromb.2019.121910_b0105","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1016\/j.jchromb.2009.09.044","article-title":"Development and validation of a liquid chromatographic method for the simultaneous determination of four anthracyclines and their respective 13-S-dihydro metabolites in plasma and saliva","volume":"877","author":"Maudens","year":"2009","journal-title":"J. Chromatogr. B. Anal. Tech. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2019.121910_b0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00007691-199906000-00022","article-title":"An improved HPLC method for therapeutic drug monitoring of daunorubicin, idarubicin, doxorubicin, epirubicin, and their 13-dihydro metabolites in human plasma","volume":"21","author":"Fogli","year":"1999","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2019.121910_b0115","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-4347(91)80485-U","article-title":"Measurement of epidoxorubicin and its metabolites by high-performance liquid chromatography using an advanced automated sample processor","volume":"572","author":"Dobbs","year":"1991","journal-title":"J. Chromatogr. B. Biomed. Sci. App."},{"key":"10.1016\/j.jchromb.2019.121910_b0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/bmc.1130040103","article-title":"Rapid quantitative determination of epirubicin and its metabolites in plasma using high performance liquid chromatography and fluorescence detection","volume":"4","author":"Dine","year":"1990","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2019.121910_b0125","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.talanta.2006.10.010","article-title":"Rapid and sensitive liquid chromatography-tandem mass spectrometry for the quantitation of epirubicin and identification of metabolites in biological samples","volume":"72","author":"Wall","year":"2007","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2019.121910_b0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0378-4347(99)00529-0","article-title":"Simultaneous determination of four anthracyclines and three metabolites in human serum by liquid chromatography-electrospray mass spectrometry","volume":"738","author":"Lach\u00e2tre","year":"2000","journal-title":"J. Chromatogr. B. Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2019.121910_b0135","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/jssc.201000026","article-title":"Simultaneous determination of anthracyclines and taxanes in human serum using online sample extraction coupled to high performance liquid chromatography with UV detection","volume":"33","author":"Bermingham","year":"2010","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jchromb.2019.121910_b0140","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1002\/rcm.1642","article-title":"Trace determination of anthracyclines in urine: A new high-performance liquid chromatography\/tandem mass spectrometry method for assessing exposure of hospital personnel","volume":"18","author":"Sottani","year":"2004","journal-title":"Rapid. Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2019.121910_b0145","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/rcm.3657","article-title":"Simultaneous determination of cyclophosphamide, ifosfamide, doxorubicin, epirubicin and daunorubicin in human urine using high-performance liquid chromatography\/electrospray ionization tandem mass spectrometry: bioanalytical method validation","volume":"22","author":"Sottani","year":"2008","journal-title":"Rapid. Commun. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2019.121910_b0150","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/bmc.3684","article-title":"Dispersive solid-phase extraction procedure coupled to UPLC-ESI-MS\/MS analysis for the simultaneous determination of thirteen cytotoxic drugs in human urine","volume":"30","author":"Fabrizi","year":"2016","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2019.121910_b0155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0731-7085(91)80104-H","article-title":"Solid-phase extraction and optimized separation of doxorubicin, epirubicin and their metabolites using reversed-phase high-performance liquid chromatography","volume":"10","author":"Nicholls","year":"1993","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2019.121910_b0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s40005-013-0076-1","article-title":"Validation of high-performance liqid chromatography method to determine epirubicin and its pharmacokinetics after intravenous bolus administration in rats","volume":"43","author":"Shin","year":"2013","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jchromb.2019.121910_b0165","unstructured":"US Food Drug Administration, FDA Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human, Services Food and Drug Administration, 2013, https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf (Accessed at: 23.08.19)."},{"key":"10.1016\/j.jchromb.2019.121910_b0170","unstructured":"European Medicines Agency, Guide to Bioanalytical Method Validation, Committee for Medicinal Products for Human Use and European Medicines Agency, 2011, https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf, (Accessed at: 23.08.19.)."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219312929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023219312929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:59:39Z","timestamp":1761605979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023219312929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":34,"alternative-id":["S1570023219312929"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2019.121910","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a high-performance liquid chromatographic method with a fluorescence detector for the analysis of epirubicin in human urine and plasma, and its application in drug monitoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2019.121910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121910"}}